Microsoft Word[removed]4295b_01_02_Cover Memo_Murphy.doc

First Page		Document Content
Date: 2007-04-09 09:20:36 Alcohols Alkynes Amines Oxybutynin Orlistat Food and Drug Administration Statin Adverse event Chemistry Organic chemistry Pharmacology		Microsoft Word[removed]4295b_01_02_Cover Memo_Murphy.doc Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 16,47 KB Share Document on Facebook

	Print Form Alabama Board of Medical Examiners P.O. Box 946, Montgomery, ALOffice-Based Surgery Adverse Event Report Form DocID: 1vm7X - View Document
	Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines for DocID: 1vily - View Document
	National Action Plan for Adverse Drug Event Prevention DocID: 1v1KN - View Document
	Microsoft Word - FINAL-Formatted-University Adverse Weather and Emergency Event Policy -eff DocID: 1uZd2 - View Document
	National Action Plan for Adverse Drug Event Prevention DocID: 1uxaR - View Document